We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US FDA Foreign Inspections Better But Still Lag Behind Domestic
US FDA Foreign Inspections Better But Still Lag Behind Domestic
November 17, 2010
U.S. Food and Drug Administration (FDA) inspection of foreign plants has increased in recent years but still pales in comparison to the level of inspections made on U.S.-based manufacturing facilities, the U.S. Government Accountability Office (GAO) has found.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor